Beta blocker reduction of mortality and reinfarction rate in survivors of myocardial infarction
Subtitle: a cost-benefit analysis
By: [by Arthur D. Little, Inc.].
Contributors: Arthur D. Little, Inc.; Pharmaceutical Manufacturers Association.
Series: Cost-effectiveness of pharmaceuticals report series -- 7.
Publisher: Pharmaceutical Manufacturers Association
Published: 1984
Place of publication: [Washington, D.C.]
Language: eng
Subjects: Adrenergic beta blockers -- Cost effectiveness.; Drugs -- Cost effectiveness.; Medical care -- Cost effectiveness.; Myocardial infarction -- Chemotherapy.
Notes: Includes bibliographical references (p. R-1-R-5).